Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CHU de Quebec-Universite Laval
With
Cancer Research Society
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
patients with ovarian serous carcinoma FIGO stage III or IV
patients showing complete response after oncological surgery and chemotherapy (paclitaxel-carboplatin, minimum 5 cycles, maximum 8 cycles), complete response being defined as 1) a negative complete physical examination 2) Serum CA-125 levels inferior to 35 U/mL 3) no evidence of diseased assessed by abdomino-perineal CT-scan
patients refraining from drinking tea other than provided by the study
patients who may absorb liquids orally
patients without any other malignancy (except for non-melanoma skin cancer)
patients not involved in an other study
patients who signed up informed consent form.
Clareo Health | Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
